Home > Research Areas > Neurological Disease > Stroke
Cat. No. Product name CAS No.
DCAPI1569 Cilostazol

Cilastazol is a 2-oxo-quinoline with vasodilator, antimitogenic, antithrombotic, and cardiotonic properties. This compound has been shown to cause inhibition of adenosine uptake, eventually resulting in changes to cAMP levels. Studies have shown Cilostazo

73963-72-1
DC8268 Eliprodil

Eliprodil is a non-competitive NMDA receptor antagonist that acts at the polyamine modulatory site.

119431-25-3
DC11080 JPI-289

JPI-289 (JPI289) is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM.

1449233-60-6
DC4237 NXY-059 (Cerovive)

NXY-059 (Cerovive) is an EGFR and HER2 autophosphorylation inhibitor, against purified EGFR and HER2 of 10.2 and 9.8 nM, respectively.

168021-79-2
DC11176 S44819

S44819 (S 44819, Egis-13529) is a novel potent, competitive, selective antagonist of the α5-GABAAR with Kd of 221 nM, IC50 of 585 nM (α5β2γ2).

1398496-82-6
DC11075 Amelparib

1227156-72-0
Page 1 / Total 1 FirstPrevNextLastGoto